BioLife Solutions Inc.

13.59-0.1100-0.80%Vol 286.58K1Y Perf -44.89%
Oct 4th, 2023 16:00 DELAYED
BID12.97 ASK14.21
Open13.71 Previous Close13.70
Pre-Market- After-Market13.59
 - -  - -%
Target Price
30.57 
Analyst Rating
Strong Buy 1.00
Potential %
124.95 
Finscreener Ranking
★★★★     52.58
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★     51.24
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★     52.65
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
18.95 
Earnings Rating
Strong Sell
Market Cap591.03M 
Earnings Date
8th Nov 2023
Alpha0.00 Standard Deviation0.19
Beta1.60 

Today's Price Range

13.4913.71

52W Range

10.4826.89

5 Year PE Ratio Range

-35.60-13.70

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-3.27%
1 Month
0.30%
3 Months
-33.38%
6 Months
-31.26%
1 Year
-44.89%
3 Years
-53.20%
5 Years
-0.29%
10 Years
-

TickerPriceChg.Chg.%
BLFS13.59-0.1100-0.80
AAPL173.661.26000.73
GOOG136.272.97002.23
MSFT318.965.56501.78
XOM111.50-4.3300-3.74
WFC38.970.30000.78
JNJ155.520.18000.12
FB196.640.99000.51
GE108.851.09001.01
JPM143.350.64000.45
Financial StrengthValueIndustryS&P 500US Markets
2.50
3.70
0.09
0.11
-13 244.70
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
29.70
-28.50
-17.00
-43.90
-76.24
RevenueValueIndustryS&P 500US Markets
117.50M
2.75
74.36
66.74
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.02-0.24-1 100.00
Q01 2023-0.10-0.27-170.00
Q04 2022-0.16-0.19-18.75
Q03 2022-0.12-0.15-25.00
Q02 2022-0.19-0.1331.58
Q01 2022-0.13-0.19-46.15
Q04 2021-0.07-0.32-357.14
Q03 20210.02-0.19-1 050.00
Earnings Per EndEstimateRevision %Trend
9/2023 QR-0.25-725.00Negative
12/2023 QR-0.20-433.33Negative
12/2023 FY-1.02-121.74Negative
12/2024 FY0.07-63.16Negative
Next Report Date8th Nov 2023
Estimated EPS Next Report-0.25
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume286.58K
Shares Outstanding43.49K
Shares Float34.79M
Trades Count5.53K
Dollar Volume3.90M
Avg. Volume449.79K
Avg. Weekly Volume417.15K
Avg. Monthly Volume484.69K
Avg. Quarterly Volume447.52K

BioLife Solutions Inc. (NASDAQ: BLFS) stock closed at 13.59 per share at the end of the most recent trading day (a -0.8% change compared to the prior day closing price) with a volume of 286.58K shares and market capitalization of 591.03M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 158 people. BioLife Solutions Inc. CEO is Michael Rice.

The one-year performance of BioLife Solutions Inc. stock is -44.89%, while year-to-date (YTD) performance is -25.33%. BLFS stock has a five-year performance of -0.29%. Its 52-week range is between 10.48 and 26.89, which gives BLFS stock a 52-week price range ratio of 18.95%

BioLife Solutions Inc. currently has a PE ratio of -7.50, a price-to-book (PB) ratio of 1.94, a price-to-sale (PS) ratio of 7.36, a price to cashflow ratio of 176.90, a PEG ratio of -0.75, a ROA of -21.60%, a ROC of -21.42% and a ROE of -25.24%. The company’s profit margin is -76.24%, its EBITDA margin is -17.00%, and its revenue ttm is $117.50 Million , which makes it $2.75 revenue per share.

Of the last four earnings reports from BioLife Solutions Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.25 for the next earnings report. BioLife Solutions Inc.’s next earnings report date is 08th Nov 2023.

The consensus rating of Wall Street analysts for BioLife Solutions Inc. is Strong Buy (1), with a target price of $30.57, which is +124.95% compared to the current price. The earnings rating for BioLife Solutions Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

BioLife Solutions Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

BioLife Solutions Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 13.00, ATR14 : 0.69, CCI20 : 18.61, Chaikin Money Flow : 0.01, MACD : -0.07, Money Flow Index : 55.53, ROC : 5.87, RSI : 50.98, STOCH (14,3) : 57.08, STOCH RSI : 0.46, UO : 56.29, Williams %R : -42.92), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of BioLife Solutions Inc. in the last 12-months were: Aby J. Mathew (Option Excercise at a value of $82 400), Aby J. Mathew (Sold 43 870 shares of value $874 368 ), Aebersold Sarah (Option Excercise at a value of $0), Aebersold Sarah (Sold 3 342 shares of value $67 896 ), Amy DuRoss (Sold 2 600 shares of value $63 310 ), Berard Todd (Option Excercise at a value of $41 200), Berard Todd (Sold 24 397 shares of value $590 973 ), Foster Karen (Option Excercise at a value of $0), Foster Karen (Sold 4 448 shares of value $92 576 ), Greef Roderick De (Option Excercise at a value of $0), Greef Roderick De (Sold 0 shares of value $0 ), Joseph Schick (Sold 3 000 shares of value $71 550 ), Karen Foster (Sold 2 145 shares of value $44 330 ), Marcus Schulz (Sold 2 976 shares of value $66 802 ), Mathew Aby (Option Excercise at a value of $247 200), Mathew Aby (Sold 127 256 shares of value $2 718 280 ), Mathew Aby J. (Option Exercise at a value of $41 200), Mathew Aby J. (Sold 20 000 shares of value $462 900 ), Michael Rice (Sold 5 938 shares of value $122 172 ), Partners Master Fund, L.P. Casdin (Buy at a value of $4 040 373), Phillips Geraint (Sold 1 539 shares of value $31 374 ), Rice Michael (Option Excercise at a value of $0), Rice Michael (Sold 47 218 shares of value $983 790 ), Roderick De Greef (Sold 179 715 shares of value $3 916 175 ), Sarah Aebersold (Sold 1 414 shares of value $29 753 ), Schulz Marcus (Option Excercise at a value of $0), Schulz Marcus (Sold 8 038 shares of value $182 714 ), Todd Berard (Option Excercise at a value of $27 810), Todd Berard (Sold 15 674 shares of value $383 269 ), Troy Wichterman (Option Excercise at a value of $1 932), Troy Wichterman (Sold 10 631 shares of value $219 874 ), Wichterman Troy (Option Excercise at a value of $1 932), Wichterman Troy (Sold 13 951 shares of value $288 180 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (100.00 %)
6 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

BioLife Solutions Inc.

BioLife Solutions Inc is active in the healthcare segment. The company is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

CEO: Michael Rice

Telephone: +1 425 402-1400

Address: 3303 Monte Villa Parkway, Bothell 98021, WA, US

Number of employees: 158

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

57%43%

 

TipRanks News for BLFS

Fri, 11 Aug 2023 11:50 GMT Analysts Are Bullish on Top Healthcare Stocks: BioLife Solutions (BLFS), Synlogic (SYBX)

- TipRanks. All rights reserved.

Mon, 07 Aug 2023 12:55 GMT BioLife Solutions (BLFS) Gets a Buy from Craig-Hallum

- TipRanks. All rights reserved.

News

Stocktwits